LON:SPEC

Inspecs Group (SPEC) Share Forecast, Price & News

GBX 343

+2.00 (+0.59%)

(As of 05/27/2022 12:00 AM ET)

Add

Compare

Today's Range: 336
▼
348
50-Day Range: 320
▼
369.90
52-Week Range: 305
▼
420

Volume: 36,192 shs
Average Volume: 55,439 shs
Market Capitalization: £348.73 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive SPEC News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspecs Group and its competitors with MarketBeat's FREE daily newsletter.

About Inspecs Group

Inspecs Group PLC designs, produces, sells, markets, and distributes fashion eyewear and original equipment manufacturer products worldwide. It provides a range of branded and private label optical and sunglasses frames. Inspecs Group PLC offers its products directly to retailers, distributors, and brand partners. The company also sells its products through a network of approximately 70,000 points of sale in 80 countries worldwide. Inspecs Group PLC was founded in 1988 and is headquartered in Bath, the United Kingdom.

May 13, 2022 | americanbankingnews.com

Inspecs Group (LON:SPEC) Trading Down 1%

May 11, 2022 | finance.yahoo.com

Is Inspecs Group plc (LON:SPEC) Potentially Undervalued?

March 15, 2022 | uk.finance.yahoo.com

Questor: Watchdog’s review casts a shadow but this pawnbroker has just raised its divi by 41pc

February 1, 2022 | morningstar.com

30Y Gilt-Bund Yield Spread to Widen as UK Interest Rates Rise

February 1, 2022 | marketwatch.com

Inspecs Sees 2021 Performance In Line Despite Covid-19 Challenges

January 10, 2022 | finance.yahoo.com

Inspecs Group (LON:SPEC) rises 9.5% this week, taking one-year gains to 29%

December 23, 2021 | marketwatch.com

Inspecs Buys Ego Eyewear for GBP6.2 Mln -- Deal Digest

December 16, 2021 | finance.yahoo.com

INSPECS Limited Eyes Centric PLM™ to Achieve Their Vision

December 8, 2021 | marketwatch.com

Inspecs Acquires Frames Distributor BoDe for EUR1.8 Mln -- Deal Digest

October 28, 2021 | lse.co.uk

Inspecs outlook confident but notes supply chain disruption

October 28, 2021 | lse.co.uk

Irish monthly retail sales up slightly, well above pre-pandemic levels

October 28, 2021 | lse.co.uk

Strong first half continues into third quarter for Inspecs

October 8, 2021 | finance.yahoo.com

Some Investors May Be Worried About Inspecs Group's (LON:SPEC) Returns On Capital

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Medical Instruments & Supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:SPEC
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: inspecs.com
Phone: 44 1125 717 000
Fax: N/A
Employees: 1,800
Year Founded: N/A

Sales & Book Value

Annual Sales: £156.43 million
Price / Sales: 2.23
Cash Flow: GBX 38.09 per share
Price / Cash Flow: 9.01
Book Value: GBX 145.30 per share
Price / Book: 2.36

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 49.88
Current Ratio: 1.83
Quick Ratio: 1.02

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 101,672,000
Free Float: N/A
Market Cap: £348.73 million
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

1.50 out of 5 stars

2.5 Analyst's Opinion

Consensus Rating
Inspecs Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 425, Inspecs Group has a forecasted upside of 23.9% from its current price of GBX 343.
Amount of Analyst Coverage
Inspecs Group has received no research coverage in the past 90 days.

5.0 Community Rank

Outperform Votes
Inspecs Group has received 5 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Inspecs Group has received 0 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Inspecs Group has received 100.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Inspecs Group and other stocks. Vote “Outperform” if you believe SPEC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SPEC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Inspecs Group does not currently pay a dividend.
Dividend Growth
Inspecs Group does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Inspecs Group insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Inspecs Group is -81.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Inspecs Group is -81.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Inspecs Group has a P/B Ratio of 2.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Inspecs Group (LON:SPEC) Frequently Asked Questions

Is Inspecs Group a buy right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inspecs Group in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Inspecs Group stock.
View analyst ratings for Inspecs Group or view top-rated stocks.
What price target have analysts set for SPEC?: 2 analysts have issued 12-month price targets for Inspecs Group's stock. Their forecasts range from GBX 425 to GBX 425. On average, they anticipate Inspecs Group's share price to reach GBX 425 in the next year. This suggests a possible upside of 23.9% from the stock's current price.
View analysts' price targets for Inspecs Group or view top-rated stocks among Wall Street analysts.
Who are Inspecs Group's key executives?: Inspecs Group's management team includes the following people:
Mr. Robin B.C. Totterman, Founder, Group CEO & Director (Age 61, Pay $189.19k)
Mr. Christopher D. Kay, Group CFO & Director (Age 59, Pay $152.18k)
Martin Bates, Sales Director
Mr. Steve Tulba, Managing Director of Inspecs Division
Mr. Richard McGonigle, Company Sec.
Who are some of Inspecs Group's key competitors?: Some companies that are related to Inspecs Group include Advanced Medical Solutions Group (AMS), CRH Medical (CRH), Bovie Medical (BVX), Tristel (TSTL), TSO3 (TOS), Akers Biosciences (AKR), Vigil Health Solutions (VGL), Omega Diagnostics Group (ODX), Relevium Technologies (RLV), AddLife AB (publ) (ADDLF), Ambu A/S (AMBBY), Ansell (ANSLY), Ansell (ANSLF), Ansell (ANN) and Austco Healthcare (AHC).
View all of SPEC's competitors.
What is Inspecs Group's stock symbol?: Inspecs Group trades on the London Stock Exchange (LON) under the ticker symbol "SPEC."
How do I buy shares of Inspecs Group?: Shares of SPEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Inspecs Group's stock price today?: One share of SPEC stock can currently be purchased for approximately GBX 343.
How much money does Inspecs Group make?: Inspecs Group has a market capitalization of £348.73 million and generates £156.43 million in revenue each year.
How many employees does Inspecs Group have?: Inspecs Group employs 1,800 workers across the globe.
What is Inspecs Group's official website?: The official website for Inspecs Group is inspecs.com.
How can I contact Inspecs Group?: The company can be reached via phone at 44 1125 717 000.

This page was last updated on 5/28/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Inspecs Group (SPEC) Share Forecast, Price & News

About Inspecs Group

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous